MHRA says 'no corners cut' to approve Pfizer's COVID-19 vaccine, side effects 'very low'

After UK achieved a major milestone by becoming first country in world to provide formal authorisation of Pfizer-BioNTech COVID-19 vaccine in a record time, CEO of MHRA, Dr June Raine reiterated that “first” priority on immunisation is safety of citizens.  Medicines and Healthcare products Regulatory ncy (MHRA) on December 2 assured that mRNA-based vaccine is 95 per cent effective “irrespective of , sex or race”. 

In news briefing, it was also informed that MHRA is working “hard” to deliver immunisation to all people starting from ones most vulnerable people. MHRA said that Pfizer-BioNTech COVID-19 vaccine is similar to or vaccines that are developed across world “and side effects are very low” with specific precautions or tests required before iculation. Raine expressed confidence in approval and assured that safety of vaccine has been scrutinised with ' stone being left unturned'.

“We have sought vice of Government's independent body, Commission on Human Medicines who have critically assessed every piece of evidence for Pfizer/BioNtech COVID19 vaccine,” British regulator CEO said before ding, “This vaccine (Pfizer-BioNTech COVID-19 vaccine) has only been approved because those strict tests have been done and complied with. Everyone can be absolutely confident that corners whatsoever have been cut: UK's medicine regulator MHRA chief Dr June Raine”

Re - WHO Chief Reiterates 'act Toger' As UK Approves Pfizer-BioNtech’s COVID-19 Vaccine

Re - UK PM Hails Approval Of Pfizer's COVID Vaccine, Avows 'will Allow Us To Reclaim Our Lives'

MHRA credits its rolling review for fast approval

In news conference, MHRA credited its rolling review process of Pfizer-BioNTech COVID-19 vaccine that began a few months ago for its speedy approval. Since process began in June, Raine explained that when companies anunced efficacy of its COVID-19 vaccine, y went ahe with approval process.

Putting an end to all questions regarding safety of immunisation develop by US drugmaker with its German partner, Raine assured that public can be ‘confident’ that all protocols matching global standards were followed before formal authorisation was provided in country. She also hailed “brilliance” of science before reiterating that vaccine meets 'rigorous high standards' of safety.

Re - Coronavirus LIVE Updates: India Reports 36,604 New Cases; UK Authorizes Pfizer Vaccine

“ reason we are here today is brilliance of science and altruism of all those people who have enlisted in clinical trials to give us tremendously robust data we have today... public can be absolutely confident that standards we have worked to are equivalent to those around world,” said Judd Raine.

Re - Pfizer-BioNTech COVID-19 Vaccine: How Is MRNA-based Vaccine Developed?

Re - Doctors React To Encouraging News As UK Approves Pfizer-BioNtech’s COVID Vaccine For Use